To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva
Condition: Fibrodysplasia Ossificans Progressiva (FOP) Interventions: Drug: INCB000928; Drug: placebo Sponsor: Incyte Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Fibrodysplasia Ossificans Progressiva | Research